Project Grant HT94252310190
Award Date
9/15/23
Completion Date
9/14/26
Dollars Obligated
$819K
Federal Agency
Defense Health Agency
Awardee
Drexel University (XF3XM9642N96)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
Drexel University was awarded a $302,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop a novel microtubule-based hypothesis for frontotemporal dementia leading to potential therapies for military personnel and veterans. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
This Project Grant award of $757,497 from the Defense Health Agency will support research by Drexel University in Philadelphia, PA to investigate the "ROLE OF PERILESIONAL REACTIVE ASTROCYTOSIS IN MELANOMA BRAIN METASTASES". The project is funded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public. Drexel University has extensive...
The federal Project Grant award of $777,537 was granted by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The award supports research to investigate associations between blood-based neurodegenerative biomarker trajectories and the risk of epilepsy, post-traumatic epilepsy, and dementia. This 3-year research project,...
This Project Grant award of $668,038.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Drexel University's research on "BIOMIMETIC NANOPARTICLE-MEDIATED DELIVERY OF IMMUNOMODULATING NUCLEIC ACIDS AS A STRATEGY TO ANTICIPATE MELANOMA DRUG RESISTANCE." The 3-year project aims to develop innovative nanoparticle-based therapies to overcome drug resistance in melanoma treatment. As a private research university, Drexel has a...
This federal Project Grant award for $506,632.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is intended to support the "ACCELERATING POST-TRAUMATIC EPILEPSY RESEARCH THROUGH DATA INTEGRATION AND VERIFIABLE ANALYSIS AT SCALE" initiative. The award was granted to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a prominent private research...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This federal Project Grant award of $322,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at Duke University, a leading private research institution, aimed at investigating the link between paternal preconception toxic exposure and autism risk. The research project will be conducted over a 2-year period from July 1, 2025 to June 30, 2027. This work aligns with the...
Drexel University received a $425,335 Project Grant award from the Department of the Army Medical Command to investigate the role of gasdermin D in melanoma brain metastases under the Military Medical Research and Development program. The three-year award beginning September 1, 2021 will support research to further understand how gasdermin D contributes to the development and progression of melanoma brain metastases. Insights gained from this work could help transform patient care and advance...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,727,257.00 to Drexel University to improve cardiometabolic health in individuals with spinal cord injuries using home-based interactive virtual gaming. The project aims to develop and evaluate a novel digital therapeutic approach to enhance physical activity, fitness, and overall health outcomes for this population. Drexel...